Skip to main content
. 2021 Oct 20;17(9):744–746. doi: 10.4244/EIJ-D-20-01093

Table 2. Clinical parameters at baseline and follow-up.

Patient 1 2 3 4 5 6
Baseline TR severity 4 3 4 4 4 4
RV ejection fraction, % 35 35 35 25 34 20
Reg. vol, ml/beat 48 33 58 57 43 42
EROA, cm2 0.3 0.2 0.7 0.3 0.3 0.4
NYHA class III III III IV III III
30 days TR severity 3 1-2 1-2 2-3 1-2 2
RV ejection fraction, % 35 35 35 35 45 29
Reg. vol, ml/beat 51 7 32 13 5 4
EROA, cm2 0.32 0.04 0.2 0.08 0.03 0.02
NYHA class I I II II I II
12 months TR severity 3 2 2 2-3 1 1
RV ejection fraction, % 44 36 35 39 45 29
Reg. vol, ml/beat 36 18 28 13 5 5
EROA, cm2 0.25 0.12 0.2 0.08 0.03 0.03
NYHA class I I II II I II
EROA: effective regurgitant orifice area; NYHA: New York Heart Association; Reg. vol: regurgitant volume; RV: right ventricle